(Ivanhoe Newswire) -- A drug approved to combat alcohol-dependence (AD)
could stop social drinkers from lighting up, too!
The U.S. Food and Drug Administration approved naltrexone in 1994 for treatment
for AD. However, non-AD smokers who drink heavily in social situations could
also benefit from naltraxone. A recent study found these smokers significantly
decreased their smoking and heavy drinking rates when pairing the drug with
nicotine patches and behavioral counseling.
"Persons with the heaviest drinking patterns appeared to benefit the most from
naltrexone, in terms of alcohol and smoking outcomes; it also increased their
quit rates more so than in lighter drinkers," Andrea C. King, a psychologist and
associate professor in the department of psychiatry at the University of Chicago
and first author of the study, was quoted as saying.
King went on to say strong inter-connections between drinking and smoking for
many people could explain their positive results.
SOURCE: Alcoholism: Clinical & Experimental Research, to be published June 2009
